119 related articles for article (PubMed ID: 6349090)
1. [Immunochemistry in ophthalmo-oncology: problems and prospects].
Iurovskaia NN; Suchkov SV
Vestn Oftalmol; 1983; (3):70-2. PubMed ID: 6349090
[No Abstract] [Full Text] [Related]
2. [Immunological studies in intraocular tumors].
Kotelianskiĭ EO
Oftalmol Zh; 1982; 37(1):54-8. PubMed ID: 7043350
[No Abstract] [Full Text] [Related]
3. Circulating melanoma-associated antigens in ocular melanoma.
Whitmore WG; Witkin SS; Ellsworth RM
Ann Ophthalmol; 1988 Jun; 20(6):212-7. PubMed ID: 3408088
[TBL] [Abstract][Full Text] [Related]
4. [Reaction of leukocyte migration inhibition in patients with uveal melanoblastoma].
Nifontova TP
Vopr Onkol; 1986; 32(4):57-61. PubMed ID: 3705529
[TBL] [Abstract][Full Text] [Related]
5. Presumed spontaneously regressed retinoblastoma.
Benson WE; Cameron JD; Furgiuele FP; Felberg NT; Yanoff M
Ann Ophthalmol; 1978 Jul; 10(7):897-9. PubMed ID: 677667
[TBL] [Abstract][Full Text] [Related]
6. Surface and cytoplasmic antigens in retinoblastoma.
Felberg NT; Donoso LA
Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1242-5. PubMed ID: 7419374
[TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen and alpha fetoprotein levels in retinoblastoma.
Minei M; Yamana Y; Ohnishi Y
Jpn J Ophthalmol; 1983; 27(1):185-92. PubMed ID: 6190029
[TBL] [Abstract][Full Text] [Related]
8. Prospects for the immunodiagnosis of ocular tumours.
Garner A; Rahi AH
Trans Ophthalmol Soc U K (1962); 1979 Apr; 99(1):150-5. PubMed ID: 398603
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions.
Keijser S; Missotten GS; Bonfrer JM; de Wolff-Rouendaal D; Jager MJ; de Keizer RJ
Br J Ophthalmol; 2006 Feb; 90(2):213-7. PubMed ID: 16424536
[TBL] [Abstract][Full Text] [Related]
10. Ocular tumors react with anti-neuroblastoma monoclonal antibodies.
Helson C; Helson L
Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1150-2. PubMed ID: 6874279
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies as diagnostic reagents for the identification and characterization of human tumor antigens.
Fink LM; Clarke SM
Prog Clin Pathol; 1984; 9():121-33. PubMed ID: 6364219
[No Abstract] [Full Text] [Related]
12. Carcinoembryonic antigen in retinoblastoma. An immunohistochemical study.
Kivelä T; Tarkkanen A
Graefes Arch Clin Exp Ophthalmol; 1983; 221(1):8-11. PubMed ID: 6357957
[TBL] [Abstract][Full Text] [Related]
13. [Carcinoembryonic antigen in retinoblastomas (author's transl)].
Gerke E; Hierholzer E; Vogel M; Höpping W; Kuwert EK
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1978 Jan; 205(2):121-7. PubMed ID: 305212
[TBL] [Abstract][Full Text] [Related]
14. Immunology of chorioretinal disorders.
Corwin JM; Weiter JJ
Surv Ophthalmol; 1981; 25(5):287-305. PubMed ID: 6111850
[TBL] [Abstract][Full Text] [Related]
15. Significance of carcinoembryonic antigen in retinoblastoma.
Das A; Roy IS; Maitra TK; Kanjilal A
Br J Ophthalmol; 1984 Apr; 68(4):252-4. PubMed ID: 6704360
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte toxicity in retinoblastoma.
Rogers GL; Vo P
South Med J; 1979 Sep; 72(9):1135-7. PubMed ID: 472839
[TBL] [Abstract][Full Text] [Related]
17. Antigenic and cellular heterogeneity of primary uveal melanomas.
Folberg R
Arch Ophthalmol; 1986 Jun; 104(6):795, 798-9. PubMed ID: 3487304
[No Abstract] [Full Text] [Related]
18. Hanganutziu-Deicher heterophile antigen in human retinoblastoma cells.
Ohashi Y; Sasabe T; Nishida T; Nishi Y; Higashi H
Am J Ophthalmol; 1983 Sep; 96(3):321-5. PubMed ID: 6351622
[TBL] [Abstract][Full Text] [Related]
19. Antigens in ocular and cutaneous melanomas.
Folberg R; Donoso LA; Herlyn MF; Koprowski H
Am J Ophthalmol; 1983 Sep; 96(3):394-5. PubMed ID: 6351625
[No Abstract] [Full Text] [Related]
20. Binding of retinoblastoma and normal sera to retinoblastoma-derived cultured cells.
Stein PC; Rand N; Char DH
Invest Ophthalmol Vis Sci; 1982 Sep; 23(3):357-63. PubMed ID: 7107161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
